111, Inc. (NASDAQ:YI – Get Free Report) saw a significant growth in short interest in the month of August. As of August 31st, there was short interest totalling 80,300 shares, a growth of 1,216.4% from the August 15th total of 6,100 shares. Based on an average trading volume of 85,600 shares, the days-to-cover ratio is currently 0.9 days.
111 Trading Down 5.1 %
NASDAQ:YI opened at $0.62 on Friday. The company has a 50-day moving average price of $0.98 and a 200-day moving average price of $1.11. The stock has a market cap of $52.74 million, a price-to-earnings ratio of -0.99 and a beta of 0.42. 111 has a 12 month low of $0.60 and a 12 month high of $2.70.
Hedge Funds Weigh In On 111
An institutional investor recently bought a new position in 111 stock. Deuterium Capital Management LLC purchased a new position in 111, Inc. (NASDAQ:YI – Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 100,000 shares of the company’s stock, valued at approximately $116,000. Deuterium Capital Management LLC owned 0.12% of 111 as of its most recent SEC filing. 21.32% of the stock is owned by institutional investors.
About 111
111, Inc, together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers.
Featured Stories
- Five stocks we like better than 111
- Stock Sentiment Analysis: How it Works
- 3 Leveraged ETFs to Multiply Returns
- What is Insider Trading? What You Can Learn from Insider Trading
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- 3 Fintech Stocks With Good 2021 Prospects
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.